| EFNA1 |
EFNA1, EPLG1, LERK1, TNFAIP4: Ephrin-A1 precursor |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
1.09E3 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
1.09E3 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
1.09E3 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
1.09E3 |
Evidence |
|
| F10 |
F10: Coagulation factor X precursor |
F5 |
F5: Coagulation factor V precursor |
1.09E3 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
F5 |
F5: Coagulation factor V precursor |
1.09E3 |
Evidence |
|
| CBX5 |
CBX5, HP1A: Chromobox protein homolog 5 |
HIST1H3A |
HIST1H3A, H3FA, HIST1H3B, H3FL, HIST1H3C, H3FC, HIST1H3D, H3FB, HIST1H3E, H3FD, |
1.08E3 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
SMURF2 |
SMURF2: E3 ubiquitin-protein ligase SMURF2 |
1.07E3 |
Evidence |
O
|
| VAMP2 |
VAMP2, SYB2: Vesicle-associated membrane protein 2 |
STX4A |
STX4, STX4A: Syntaxin-4 |
1.07E3 |
Evidence |
O
|
| CHC1 |
RCC1: RCC1-I (Fragment) |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
1.07E3 |
Evidence |
O
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
1.06E3 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
SHC3 |
SHC3, NSHC, SHCC: SHC-transforming protein 3 |
1.04E3 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
1.04E3 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
1.04E3 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
1.04E3 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
1.04E3 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
1.04E3 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
1.04E3 |
Evidence |
|
| MTA2 |
MTA1L1, MTA2, PID: Metastasis-associated protein MTA2 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
1.02E3 |
Evidence |
|
| EPHA8 |
EPHA8, EEK, KIAA1459: Ephrin type-A receptor 8 precursor |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
1.02E3 |
Evidence |
|
| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
TSG101 |
TSG101: Tumor susceptibility gene 101 protein |
1.01E3 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
GRAP |
GRAP: GRB2-related adapter protein |
1.01E3 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
1.01E3 |
Evidence |
|
| TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
TUBB2A |
TUBB2A, TUBB2: Tubulin beta-2A chain |
1.00E3 |
Evidence |
|
| MSH6 |
MSH6, GTBP: DNA mismatch repair protein MSH6 |
CCNB1 |
Cyclin B1 |
953.000 |
Evidence |
|
-